BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29486292)

  • 1. Expression profiles of stemness genes in gastrointestinal stromal tumor.
    Bai C; Liu X; Xu J; Qiu C; Wang R; Zheng J
    Hum Pathol; 2018 Jun; 76():76-84. PubMed ID: 29486292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior.
    Kalfusova A; Hilska I; Krskova L; Kalinova M; Linke Z; Kodet R
    Neoplasma; 2016; 63(3):484-92. PubMed ID: 26952515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (BMI-1) Gene and Protein in Gastrointestinal Stromal Tumors.
    Zhu K; Li K; Yuan DW; Xu G; Kang L; Dang CX; Zhang Y
    Med Sci Monit; 2018 Sep; 24():6414-6421. PubMed ID: 30209248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway.
    Bai F; Zhang N; Fang W; He X; Zheng Y; Gu D
    Mol Carcinog; 2020 Jun; 59(6):661-669. PubMed ID: 32339330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).
    Kou Y; Zhao Y; Bao C; Wang Q
    Cell Biochem Biophys; 2015 Jun; 72(2):571-8. PubMed ID: 25586720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of long non-coding RNAs and mRNAs associated with malignant transformation of gastrointestinal stromal tumors.
    Yin X; Yin Y; Dai L; Shen C; Chen N; Li J; Cai Z; Jiang Z; Wang J; Zhao Z; Chen X; Deng H; Zhang B
    Cell Death Dis; 2021 Jul; 12(7):669. PubMed ID: 34218261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Expression of
    Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
    Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Fujita A; Oda Y
    Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
    Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
    World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
    Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
    PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
    Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
    Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.
    Choi HJ; Lee H; Kim H; Kwon JE; Kang HJ; You KT; Rhee H; Noh SH; Paik YK; Hyung WJ; Kim H
    Int J Cancer; 2010 Apr; 126(7):1640-50. PubMed ID: 19795448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
    Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
    Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.